Times are displayed in (UTC-05:00) Central Time (US & Canada) Change
5/6/2024 | 11:30 AM – 12:45 PM | Exhibit Hall F1
Poster Session—Immunotherapy and Cancer Vaccines (AM)
Investigating the potential of CD8α:MyD88 to restrain terminal exhaustion in tumor-specific T cells
(P203)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 203
Abstract ID: 4475
Presenting Author:
Gabriella Albert, Univ. of Colorado Anschutz Med. Campus
Co-Authors:
Phoebe Cao, Univ. of Colorado Anschutz Med. Campus; Eduardo Davila, Univ. of Colorado Anschutz Med. Campus;
View Abstract Details
Epigenetic regulators of clonal hematopoiesis control CD8 T cell stemness during immunotherapy
(P205)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 205
Abstract ID: 4169
Presenting Author:
Tae Gun Kang, St. Jude Children’s Res. Hosp.
Co-Authors:
Xin Lan, St. Jude Children’s Res. Hosp.; Tian Mi, St. Jude Children’s Res. Hosp.; Shanta Ali, St. Jude Children’s Res. Hosp.; Sofia Bentivegna, Copenhagen Univ. Hosp., Rigshospitalet; Josh Jang, Van Andel Inst.; Marianne L. Spatz4, Merck & Co.; Jin-hwan Han, Merck & Co.; Balthasar Clemens Schlotmann, Copenhagen Univ. Hosp., Rigshospitalet; Jakob Schmidt Jespersen, Univ. of Copenhagen; Stephen Baylin, Kimmel Comp. Cancer Ctr., Johns Hopkins Univ.; Peter Jones, Van Andel Inst.; Casey O’Connell, Univ. of Southern California; Kirsten Grønbæk, Copenhagen Univ. Hosp., Rigshospitalet; Ben Youngblood, St. Jude Children’s Res. Hosp.; Caitlin C. Zebley, St. Jude Children’s Res. Hosp.;
View Abstract Details
Antibody Blockade of MHC-I/Ly49 Interactions Enhances Humoral and Cellular Immunity
(P207)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 207
Abstract ID: 4901
Presenting Author:
Soha Kazmi, NIAID, NIH
Co-Authors:
Abir Panda, NIAID, NIH; Ethan Shevach, NIAID, NIH;
View Abstract Details
Nanoparticle-based Methionine and AICAR delivery Elicits Robust Antitumor Immune Response.
(P209)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 209
Abstract ID: 4871
Presenting Author:
YE GU, Yeungnam University
Co-Authors:
Loc Bao Nguyen, Yeungnam University; Mahesh Pandit, Stanford Univ.; Sunil Mishra, Yeungnam University; Ram Hari Pokhrel, Yeungnam University; Jong-Oh Kim, Yeungnam University; Jae-Hoon Chang, Yeungnam University;
View Abstract Details
Anti-tumor effects of anti-CD3ε Fab fragments depend on tumor antigen availability
(P211)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 211
Abstract ID: 5444
Presenting Author:
Hien Huynh, Univ. of Missouri, Columbia, Univ. of Missouri, Columbia
Co-Authors:
Chandrashekara M Puthanapura, Univ. of Missouri, Columbia; Onekachi Okpasuo, Univ. of Missouri, Columbia; Liangyu Wang, Univ. of Missouri, Columbia; Vijay Radhakrishnan, Univ. of Missouri, Columbia; Christa Cheatham, Univ. of Missouri, Columbia; Nhan Vu, Univ. of Missouri, Columbia; Curtis Pritzl, Univ. of Missouri, Columbia; Adam G Schrum, Univ. of Missouri, Columbia; Emma Teixeiro, Univ. of Missouri, Columbia; Diana Gil, Univ. of Missouri, Columbia;
View Abstract Details
Repurposing varicella zoster virus and human papillomavirus vaccines for local immunotherapy against solid tumors
(P215)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 215
Abstract ID: 5315
Presenting Author:
Nicolas Cuburu, NCI, NIH
Co-Authors:
Shiv K Sethi, NCI, NIH; Claire E Bradley, NCI, NIH; Lukas Bialkowski, NCI, NIH; Pang Y Yuk, NCI, NIH; Cynthia D Thompson, NCI, NIH; John T Schiller;
View Abstract Details
αPDL2 treats melanoma in an IL17 and IFNγ dependent mechanism mediated by CD8 and γδ T cells
(P217)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 217
Abstract ID: 5134
Presenting Author:
Chris Tanner, Dartmouth Cancer Ctr.
Co-Authors:
Carlos Ontiveros, Dartmouth Cancer Ctr.; Haiyan Bai, Dartmouth Cancer Ctr.; Myrna Garcia;
View Abstract Details
Developing novel cancer patient-derived xenografts (PDXs) that support evaluation of immunotherapies enhancing human T cell functionality in the absence of graft versus host disease
(P219)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 219
Abstract ID: 5962
Presenting Author:
Christa Cheatham, Univ. of Missouri, Columbia
Co-Authors:
Vijay Radhakrishnan, Univ. of Missouri Sch. of Med.; Onyekachi Juliet Okpasuo, Univ. of Missouri Sch. of Med.; Chandrashekara Puthanapura Mahadevappa, Univ. of Missouri Sch. of Med.; FNU Kiran, Univ. of Missouri Sch. of Med.; Deepak Kumar, Univ. of Missouri Sch. of Med.; Jussuf Kaifi, Univ. of Missouri, Columbia; Jeffrey Bryan, Univ. of Missouri Col. of Vet. Med.; Adam Schrum, Univ. of Missouri Sch. of Med.; Diego Avella, Northwestern Univ. Feinberg Sch. of Med.; Diana Gil, Univ. of Missouri Sch. of Med.;
View Abstract Details
Understanding the impact of microbiome modulations on T cell-mediated immunotherapy for metastatic osteosarcoma (mOS)
(P221)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 221
Abstract ID: 5887
Presenting Author:
Michelle Di Palma, Arizona State Univ.
Co-Authors:
Lizbeth Nieves; Sarah Smeh, Arizona State Univ.; Joseph N Blattman, Arizona State Univ.;
View Abstract Details
Inducing Neoepitopes in Cancer Cells Unmasks Tumors to the Immune System
(P223)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 223
Abstract ID: 6059
Presenting Author:
Lisa Volpatti, Univ. of Chicago Pritzker Sch. of Molecular Engr.
Co-Authors:
Gustavo Borjas, Univ. of Chicago Pritzker Sch. of Molecular Engr.; Joshua Rosenthal, Marine Bio. Lab.; Jeffrey Hubbell, Univ. of Chicago Pritzker Sch. of Molecular Engr.;
View Abstract Details
Replication-attenuated r3LCMV vectors potentiate tumor control via IFN-I
(P225)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 225
Abstract ID: 4694
Presenting Author:
Bakare Awakoaiye, Northwestern Univ. Feinberg Sch. of Med.
Co-Authors:
Young Rock Chung, Northwestern Univ. Feinberg Sch. of Med.; Tanushree Dangi, Northwestern Univ. Feinberg Sch. of Med.; Slim Fourati, Northwestern Univ. Feinberg Sch. of Med.; Pablo Penaloza-MacMaster, Northwestern Univ. Feinberg Sch. of Med.;
View Abstract Details